ARCHIVES

Control AC Hear Report On High Risk conference, Messer Survey

This article is from The Cancer Letter archive.

Vol. 01 No. 31 | September 6, 1974

Download PDF Visit The Full Archive

Related Articles

FDA Approves Taxotere For Node+ Breast Cancer

August 27, 2004

Letter; ASSIST Prevents Cancer, Should Remain in NCI Portfolio

July 4, 1997

Pill Associated With Cancer In BRCA1 Mutation Carriers

January 31, 2003

“NIH Reveres, Honors, respects And Defends One And Only One Mechanisms’ – R01s

September 20, 1991

Group Chairmen Object To “Directive” Language In Proposed Intergroup Study Guidelines

January 13, 1984

FDA Approves Silicone Gel Breast Implants, Requires 10 Years Of Patient Follow-Up

November 24, 2006